1. Home
  2. MVIS vs HOWL Comparison

MVIS vs HOWL Comparison

Compare MVIS & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroVision Inc.

MVIS

MicroVision Inc.

HOLD

Current Price

$1.20

Market Cap

45.0M

Sector

Technology

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.99

Market Cap

46.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MVIS
HOWL
Founded
1993
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.0M
46.7M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
MVIS
HOWL
Price
$1.20
$0.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.2M
455.5K
Earning Date
10-28-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.91
18.40
EPS
N/A
★ N/A
Revenue
★ $664,000.00
N/A
Revenue This Year
$1,017.55
N/A
Revenue Next Year
$48.15
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.23
$0.27
52 Week High
$4.90
$1.83

Technical Indicators

Market Signals
Indicator
MVIS
HOWL
Relative Strength Index (RSI) 39.83 57.50
Support Level $0.56 $0.86
Resistance Level $1.89 $1.14
Average True Range (ATR) 0.11 0.05
MACD 0.00 -0.00
Stochastic Oscillator 20.83 50.82

Price Performance

Historical Comparison
MVIS
HOWL

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: